Ocak, B. Et Al. 2024. Can Cytoreductive Nephrectomy Improve Outcomes of Nivolumab Treatment in Patients with Metastatic Clear-Cell Renal Carcinoma?. Current Oncology , vol.31, no.9 , 5195-5205.

Ocak, B., ŞAHİN, A. B., Ertürk, I., Korkmaz, M., Erdem, D., Cakıroglu, U., ... Karaca, M.(2024). Can Cytoreductive Nephrectomy Improve Outcomes of Nivolumab Treatment in Patients with Metastatic Clear-Cell Renal Carcinoma?. Current Oncology , vol.31, no.9, 5195-5205.

Ocak, Birol Et Al. "Can Cytoreductive Nephrectomy Improve Outcomes of Nivolumab Treatment in Patients with Metastatic Clear-Cell Renal Carcinoma?," Current Oncology , vol.31, no.9, 5195-5205, 2024

Ocak, Birol Et Al. "Can Cytoreductive Nephrectomy Improve Outcomes of Nivolumab Treatment in Patients with Metastatic Clear-Cell Renal Carcinoma?." Current Oncology , vol.31, no.9, pp.5195-5205, 2024

Ocak, B. Et Al. (2024) . "Can Cytoreductive Nephrectomy Improve Outcomes of Nivolumab Treatment in Patients with Metastatic Clear-Cell Renal Carcinoma?." Current Oncology , vol.31, no.9, pp.5195-5205.

@article{article, author={Birol Ocak Et Al. }, title={Can Cytoreductive Nephrectomy Improve Outcomes of Nivolumab Treatment in Patients with Metastatic Clear-Cell Renal Carcinoma?}, journal={Current Oncology}, year=2024, pages={5195-5205} }